Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not

被引:0
|
作者
Kiyoko Iwatsuki-Horimoto [1 ]
Maki Kiso [2 ]
Mutsumi Ito [1 ]
Seiya Yamayoshi [2 ]
Yoshihiro Kawaoka [1 ]
机构
[1] University of Tokyo,Division of Virology, Institute of Medical Science
[2] University of Tokyo,The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA)
[3] National Center for Global Health and Medicine Research Institute,The Research Center for Global Viral Diseases
[4] University of Tokyo,Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science
[5] University of Wisconsin-Madison,Department of Pathobiological Sciences, Influenza Research Institute, School of Veterinary Medicine
来源
npj Viruses | / 2卷 / 1期
关键词
D O I
10.1038/s44298-024-00068-8
中图分类号
学科分类号
摘要
Syrian hamster are sensitive to SARS-CoV-2 and widely used as an animal model of COVID-19. In contrast, mice are not readily infected by the ancestral strains of SARS-CoV-2 because of differences in their angiotensin-converting enzyme 2 (ACE2) receptors. Thus, even among rodents, susceptibility to SARS-CoV-2 varies. Knowledge of virus transmissibility from humans to pet rodents is important for public health to assess the potential for transmission in the home and pet breeding and selling facilities. In this study, we assessed the sensitivity of guinea pigs and gerbils to SARS-CoV-2 isolated from humans, and found that gerbils are susceptible to SARS-CoV-2, but guinea pigs are not. Pet sellers often display hamsters with high susceptibility to SARS-CoV-2 in the same area as gerbils, so caution should be exercised during COVID-19 outbreaks.
引用
收藏
相关论文
共 50 条
  • [21] Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Cheng, Qi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 62 - 83
  • [22] Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection
    Li, Tao
    Wang, Li
    Wang, Huihui
    Li, Xuemei
    Zhang, Shubing
    Xu, Yuanhong
    Wei, Wei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [23] SARS-CoV-2 Vaccines
    Creech, C. Buddy
    Walker, Shannon C.
    Samuels, Robert J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1318 - 1320
  • [24] SARS-CoV-2 and dentistry
    Ortega, Karem L.
    Rodrigues de Camargo, Alessandra
    Bertoldi Franco, Juliana
    Mano Azul, Antonio
    Perez Sayans, Mario
    Braz Silva, Paulo Henrique
    CLINICAL ORAL INVESTIGATIONS, 2020, 24 (07) : 2541 - 2542
  • [25] SARS-CoV-2 in humans
    Binder, Marco
    Wyler, Emanuel
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2021, 134
  • [26] Spread of SARS-CoV-2
    Stower, Hannah
    NATURE MEDICINE, 2020, 26 (04) : 465 - 465
  • [27] Sequencing SARS-CoV-2
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2021, 99 (02) : 79 - 79
  • [28] SARS-CoV-2 in Semen
    Wiwanitkit, Viroj
    UROLOGIA INTERNATIONALIS, 2020, 104 (11-12) : 1000 - 1000
  • [29] The origin of SARS-CoV-2
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1018 - 1019
  • [30] The heart and SARS-CoV-2
    Gonzalez-Calle, David
    Eiros, Rocio
    Sanchez, Pedro L.
    MEDICINA CLINICA, 2022, 159 (09): : 440 - 446